JP2023536509A5 - - Google Patents
Info
- Publication number
- JP2023536509A5 JP2023536509A5 JP2023508083A JP2023508083A JP2023536509A5 JP 2023536509 A5 JP2023536509 A5 JP 2023536509A5 JP 2023508083 A JP2023508083 A JP 2023508083A JP 2023508083 A JP2023508083 A JP 2023508083A JP 2023536509 A5 JP2023536509 A5 JP 2023536509A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- trifluoromethyl
- bis
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010779964 | 2020-08-05 | ||
| CN202010779964.6 | 2020-08-05 | ||
| PCT/CN2021/110506 WO2022028459A1 (en) | 2020-08-05 | 2021-08-04 | Pharmaceutical composition of aquaporin inhibitor and preparation method thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023536509A JP2023536509A (ja) | 2023-08-25 |
| JP2023536509A5 true JP2023536509A5 (cg-RX-API-DMAC10.html) | 2024-08-06 |
| JP7877294B2 JP7877294B2 (ja) | 2026-06-22 |
Family
ID=80120008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023508083A Active JP7877294B2 (ja) | 2020-08-05 | 2021-08-04 | アクアポリン阻害剤の医薬組成物およびその製造方法 |
Country Status (12)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104602682B (zh) | 2012-05-08 | 2018-12-14 | 埃罗米克斯公司 | 用于治疗水通道蛋白介导的疾病的化合物 |
| EP3065729A4 (en) | 2013-11-06 | 2017-05-31 | Aeromics, Inc. | Novel formulations |
| AU2017261828B2 (en) | 2016-05-13 | 2023-04-13 | Aeromics, Inc. | Crystals |
| WO2024208207A1 (zh) * | 2023-04-03 | 2024-10-10 | 拜西欧斯(北京)生物技术有限公司 | 一种双取代萘化合物及其药物组合物和用途 |
| WO2025075479A1 (ko) * | 2023-10-04 | 2025-04-10 | 이화여자대학교 산학협력단 | 아쿠아포린 4 억제제의 심방세동 치료 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7626042B2 (en) * | 2002-06-06 | 2009-12-01 | Institute Of Medicinal Molecular Design, Inc. | O-substituted hydroxyaryl derivatives |
| US9316633B2 (en) * | 2006-11-16 | 2016-04-19 | The Regents Of The University Of California | Methods for identifying inhibitors of solute transporters |
| CN104602682B (zh) | 2012-05-08 | 2018-12-14 | 埃罗米克斯公司 | 用于治疗水通道蛋白介导的疾病的化合物 |
| EP3065729A4 (en) | 2013-11-06 | 2017-05-31 | Aeromics, Inc. | Novel formulations |
| SG11201604477SA (en) * | 2013-12-13 | 2016-07-28 | Vertex Pharma | Prodrugs of pyridone amides useful as modulators of sodium channels |
| AU2017261828B2 (en) * | 2016-05-13 | 2023-04-13 | Aeromics, Inc. | Crystals |
-
2021
- 2021-08-04 BR BR112023002129A patent/BR112023002129A2/pt unknown
- 2021-08-04 KR KR1020237007248A patent/KR20230137284A/ko active Pending
- 2021-08-04 EP EP21852147.4A patent/EP4192442A4/en active Pending
- 2021-08-04 JP JP2023508083A patent/JP7877294B2/ja active Active
- 2021-08-04 WO PCT/CN2021/110506 patent/WO2022028459A1/en not_active Ceased
- 2021-08-04 CN CN202180057413.1A patent/CN117337182A/zh active Pending
- 2021-08-04 MX MX2023001493A patent/MX2023001493A/es unknown
- 2021-08-04 AU AU2021323181A patent/AU2021323181A1/en active Pending
- 2021-08-04 IL IL300341A patent/IL300341A/en unknown
- 2021-08-04 US US18/040,618 patent/US20230293556A1/en active Pending
- 2021-08-04 CA CA3187716A patent/CA3187716A1/en active Pending
- 2021-08-05 TW TW110128921A patent/TW202228714A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7475395B2 (ja) | 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法 | |
| CA2814371C (en) | Use of malononitrilamides in neuropathic pain | |
| KR20120013404A (ko) | 화상 치료 조성물 및 방법 | |
| JP2023512763A5 (cg-RX-API-DMAC10.html) | ||
| JP2022533981A5 (cg-RX-API-DMAC10.html) | ||
| KR20200036920A (ko) | 행동 변경 치료 방법 | |
| JP2025142200A (ja) | ダプトマイシン製剤 | |
| JP7224687B2 (ja) | 局所注射用組成物 | |
| JP2023536509A (ja) | アクアポリン阻害剤の医薬組成物およびその製造方法 | |
| DD298478A5 (de) | Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen | |
| JP2022507838A (ja) | エドキサバンを含む薬学的製剤およびその製造方法 | |
| JP2025134747A5 (cg-RX-API-DMAC10.html) | ||
| US20240382455A1 (en) | Composition containing 1h-pyrazole-3-amide-based compound derivative for prevention or treatment of fibrosis | |
| JP2019516722A (ja) | 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用 | |
| JP2021501739A (ja) | ホスホコリン誘導体を含有する脂肪分解組成物 | |
| WO2011149012A1 (ja) | イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用 | |
| JP2023501397A (ja) | 肥満細胞疾患および好酸球性障害の治療 | |
| WO2024139978A1 (zh) | Vofopitant用于治疗肺纤维化的用途 | |
| EA008145B1 (ru) | Инъецируемая галеновая форма флупиртина | |
| CN111494370B (zh) | Pyr3在制备保护肝损伤的药物中的应用 | |
| IL318683A (en) | Novel salts and crystals | |
| CN107496426A (zh) | 含伊马替尼或其药学上可接受的盐作为有效成分的用于治疗或预防血管渗透性疾病的组合物 | |
| JP6907174B2 (ja) | アミロイド線維形成の抑制又は阻害剤 | |
| AU2016364380B2 (en) | Formulations for intravenous injection of danirixin | |
| KR102832710B1 (ko) | 당뇨병 또는 당뇨합병증의 치료를 위한 4-헥실레조르시놀의 용도 |